CytoSorbents makes blood purification cartridges that remove toxins and inflammatory substances from blood for hospitals and veterinary clinics. It last closed at $4.52 on Nov 17, down 6.80% on the day.
Only 1 firm rated CTSO in the past 90 days, not enough for a consensus
Average 12-month target
$9.50
▲ 110.2% upside
Based on 1 analyst who set a price target on CTSO in the past 90 days. The average target is $9.50, with a high of $9.50 and a low of $9.50, compared with the last close of $4.52.
Low $9.50Avg $9.50High $9.50
Blue marker: last close $4.52
Highest target$9.50
Average target$9.50
Lowest target$9.50
Latest rating changes
WBB SecuritiesInitiated
Oct 21Buy$9.50
Date
Firm
Action
Rating
Price target
Oct 21
WBB Securities
Initiated
Buy
$9.50
Loading…
Technical Analysis
CTSO · as of the Nov 17 close · updated after every close
Downtrend
The stock is 10% below its 20 day and 6% below its 50 day average. It is 99% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 46). The nearest support is the swing low (Oct 26) at $4.10, and the nearest resistance the Pivot at $4.76.
Short trendBearish
Long trendBearish
MomentumWeak
StretchNormal
VolatilityHigh, 15.4%/day
Key levels
$17.0052 week high+276.1%
$8.98200 day average+98.7%
$6.24Swing high (Nov 10)+38.1%
$6.09100 day average+34.7%
$5.32Pivot R1+17.7%
$4.9920 day average+10.4%
$4.7950 day average+6.0%
$4.76Pivot+5.3%
$4.52Last close
$4.10Swing low (Oct 26)−9.3%
$3.96Pivot S1−12.4%
$2.8452 week low−37.2%
Indicators
RSI (14)
45.51
Middle of its range
Neutral
MACD
0.07
Below its signal line
Bearish
Stochastic
32.7
Middle of its range
Neutral
ADX (14)
19.7
No clear trend
Williams %R
-77.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-40.5
Oversold below −100, overbought above 100
Neutral
Rate of change
−0.4%
Change over 10 sessions
Bearish
ATR (14)
$0.70
Typical daily range, 15.4% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
Downtrend, nearing oversold
Short trendBearish
Long trendBearish
MomentumFading
StretchNear oversold
VolatilityHigh, 36.9%/day
Key levels
$17.0052 week high+276.1%
$8.98200 day average+98.7%
$6.24Swing high (Nov 10)+38.1%
$6.09100 day average+34.7%
$5.32Pivot R1+17.7%
$4.9920 day average+10.4%
$4.7950 day average+6.0%
$4.76Pivot+5.3%
$4.52Last close
$4.10Swing low (Oct 26)−9.3%
$3.96Pivot S1−12.4%
$2.8452 week low−37.2%
Indicators
RSI (14)
34.66
Weak, oversold below 30
Neutral
MACD
-1.53
Above its signal line
Bullish
Stochastic
28.7
Middle of its range
Neutral
ADX (14)
10.9
No clear trend
Williams %R
-74.5
Oversold below −80, overbought above −20
Neutral
CCI (20)
-64.8
Oversold below −100, overbought above 100
Neutral
Rate of change
−29.5%
Change over 10 sessions
Bearish
ATR (14)
$1.67
Typical daily range, 36.9% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for CTSO
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
Signal name goes hereSince a recent date
9 times
+0.0%
What happened before
See how CTSO did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.
November seasonalityHow CTSO usually does this month. See Seasonality
Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.
Seasonality
How CTSO has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2006.
From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.
AI Auto Pilots
Paper trading
StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether CTSO is in one of them and how their past CTSO trades turned out.
CytoSorbents is a medical device company based in Princeton, New Jersey. It makes blood purification cartridges filled with porous polymer beads that remove harmful substances from blood. Its main product, CytoSorb, is sold to hospitals for use in intensive care and cardiac surgery, where it connects to blood pumps already in use. The company also sells products for emergency care in animals and is seeking U.S. approval for a device that removes certain blood thinners during heart surgery.